|
Neoplasia
Citations 431-440 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
- Mohamed L. Sorror, Barry E. Storer, David G. Maloney, Brenda M. Sandmaier, Paul J. Martin, and Rainer Storb
Blood 2008; 111: 446-452.
[Abstract]
[Full text]
[PDF]
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma
- Richard F. Little, Karen Aleman, Pallavi Kumar, Kathleen M. Wyvill, James M. Pluda, Elizabeth Read-Connole, Victoria Wang, Stefania Pittaluga, Andrew T. Catanzaro, Seth M. Steinberg, and Robert Yarchoan
Blood 2007; 110: 4165-4171.
[Abstract]
[Full text]
[PDF]
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival
- Michelle A. Elliott, Mark R. Litzow, Louis L. Letendre, Robert C. Wolf, Curtis A. Hanson, Ayalew Tefferi, and Martin S. Tallman
Blood 2007; 110: 4172-4174.
[Abstract]
[Full text]
[PDF]
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
- Dorothée Duluc, Yves Delneste, Fang Tan, Marie-Pierre Moles, Linda Grimaud, Julien Lenoir, Laurence Preisser, Ignacio Anegon, Laurent Catala, Norbert Ifrah, Philippe Descamps, Erick Gamelin, Hugues Gascan, Mohamed Hebbar, and Pascale Jeannin
Blood 2007; 110: 4319-4330.
[Abstract]
[Full text]
[PDF]
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity
- Jens Dannull, Diem-Thu Lesher, Robert Holzknecht, Wenning Qi, Gabi Hanna, Hilliard Seigler, Douglas S. Tyler, and Scott K. Pruitt
Blood 2007; 110: 4341-4350.
[Abstract]
[Full text]
[PDF]
Constitutively active STAT6 predisposes toward a lymphoproliferative disorder
- Mark H. Kaplan, Sarita Sehra, Hua-Chen Chang, John T. O'Malley, Anubhav N. Mathur, and Heather A. Bruns
Blood 2007; 110: 4367-4369.
[Abstract]
[Full text]
[PDF]
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30
- Ezogelin Oflazoglu, Ivan J. Stone, Kristine A. Gordon, Iqbal S. Grewal, Nico van Rooijen, Che-Leung Law, and Hans-Peter Gerber
Blood 2007; 110: 4370-4372.
[Abstract]
[Full text]
[PDF]
Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPAR cross talk with NF- B and C/EBPβ
- Li Hua Wang, Xiao Yi Yang, Xiaohu Zhang, and William L. Farrar
Blood 2007; 110: 4373-4384.
[Abstract]
[Full text]
[PDF]
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
- Detlef Haase, Ulrich Germing, Julie Schanz, Michael Pfeilstöcker, Thomas Nösslinger, Barbara Hildebrandt, Andrea Kundgen, Michael Lübbert, Regina Kunzmann, Aristoteles A. N. Giagounidis, Carlo Aul, Lorenz Trümper, Otto Krieger, Reinhard Stauder, Thomas H. Müller, Friedrich Wimazal, Peter Valent, Christa Fonatsch, and Christian Steidl
Blood 2007; 110: 4385-4395.
[Abstract]
[Full text]
[PDF]
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
- Ken H. Young, Dennis D. Weisenburger, Bhavana J. Dave, Lynette Smith, Warren Sanger, Javeed Iqbal, Elias Campo, Jan Delabie, Randy D. Gascoyne, German Ott, Lisa Rimsza, H. Konrad Müller-Hermelink, Elaine S. Jaffe, Andreas Rosenwald, Louis M. Staudt, Wing C. Chan, and Timothy C. Greiner
Blood 2007; 110: 4396-4405.
[Abstract]
[Full text]
[PDF]
|
|
